Bill > HR8000

This bill, known as the "End Needless Distribution of 7-OH Act" or "END 7-OH Act," proposes to amend the Controlled Substances Act, which is the primary federal law regulating drugs in the United States. Specifically, it aims to classify synthetic 7-hydroxymitragynine as a Schedule I controlled substance. Schedule I is the most restrictive category, reserved for drugs with a high potential for abuse, no currently accepted medical use in treatment in the United States, and a lack of accepted safety for use under medical supervision. The bill clarifies that this scheduling applies to synthetic versions of 7-hydroxymitragynine but explicitly excludes 7-hydroxymitragynine that is naturally found in the plant Mitragyna speciosa, commonly known as kratom. This distinction is important because kratom itself is a plant that contains various compounds, and the bill targets only the synthetic form of one of its active alkaloids.

Business and Industry

https://www.congress.gov/bill/119th-congress/house-bill/8000/all-info